Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off a ventilator within a month, despite double the risk of additional infection.

For more information about this story visit: https://labblog.uofmhealth.org/body-work/drug-calms-cytokine-storm-associated-45-lower-risk-of-dying-among-covid-19-patients-on

Hosted on Acast. See acast.com/privacy for more information.